Zurich Cantonal Bank
GH icon

Zurich Cantonal Bank’s Guardant Health GH Stock Holding History

Zurich Cantonal Bank’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04M Buy
+43,696
New +$4.39M 0.01% 731
2025
Q4 		– Sell
-34,689
Closed -$3.1M – 2941
2025
Q3 		$2.17M Buy
34,689
+948
+3% +$51.6K 0.01% 882
2025
Q2 		$1.76M Buy
33,741
+612
+2% +$27.3K ﹤0.01% 927
2025
Q1 		$1.41M Buy
33,129
+2,641
+9% +$114K ﹤0.01% 981
2024
Q4 		$931K Buy
30,488
+1,502
+5% +$42.3K ﹤0.01% 1219
2024
Q3 		$665K Buy
28,986
+1,844
+7% +$52.2K ﹤0.01% 1363
2024
Q2 		$784K Buy
27,142
+4,651
+21% +$108K ﹤0.01% 1194
2024
Q1 		$464K Sell
22,491
-57
-0.3% -$1.22K ﹤0.01% 1507
2023
Q4 		$610K Sell
22,548
-993
-4% -$26K ﹤0.01% 1378
2023
Q3 		$698K Buy
23,541
+1,531
+7% +$53.8K ﹤0.01% 1199
2023
Q2 		$788K Buy
22,010
+3,775
+21% +$108K ﹤0.01% 1069
2023
Q1 		$427K Buy
18,235
+1,672
+10% +$47.8K ﹤0.01% 1387
2022
Q4 		$451K Buy
16,563
+2,102
+15% +$96.2K ﹤0.01% 1313
2022
Q3 		$778K Buy
14,461
+935
+7% +$48K ﹤0.01% 943
2022
Q2 		$546K Sell
13,526
-163
-1% -$8.08K ﹤0.01% 1169
2022
Q1 		$907K Sell
13,689
-1,272
-9% -$87K ﹤0.01% 983
2021
Q4 		$1.5M Buy
14,961
+3,469
+30% +$359K 0.01% 834
2021
Q3 		$1.44M Buy
11,492
+400
+4% +$47.5K 0.01% 832
2021
Q2 		$1.38M Buy
11,092
+233
+2% +$31.3K 0.01% 812
2021
Q1 		$1.66M Buy
10,859
+1,967
+22% +$297K 0.01% 745
2020
Q4 		$1.15M Buy
8,892
+2,579
+41% +$297K 0.01% 899
2020
Q3 		$706K Hold
6,313
– – 0.01% 944
2020
Q2 		$512K Buy
6,313
+3,220
+104% +$259K ﹤0.01% 993
2020
Q1 		$215K Buy
3,093
+805
+35% +$61.8K ﹤0.01% 1196
2019
Q4 		$179K Hold
2,288
– – ﹤0.01% 1401
2019
Q3 		$146K Buy
2,288
+1,408
+160% +$124K ﹤0.01% 1411
2019
Q2 		$76K Buy
+880
New +$67.2K ﹤0.01% 1781

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's GH Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Guardant Health (GH) in Q1 2026: 43,696 shares worth $4.04M. The stake represents 0.01% of the portfolio and ranks #731 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in GH as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in GH in Q2 2019 and has held it in 27 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Zurich Cantonal Bank held 43,696 shares of Guardant Health worth $4.04M as of Q1 2026.
  • Guardant Health was a new Zurich Cantonal Bank position in Q1 2026.
  • Guardant Health made up 0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #731 holding.
  • Zurich Cantonal Bank first reported a position in Guardant Health in Q2 2019 and has held it in 27 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.